Author Correction: Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation

Jennifer Derrien^#¹, Sarah Gastineau^#¹, Antoine Frigout¹, Nils Giordano¹, Mia Cherkaoui¹, Victor Gaborit^{1

2}, Rémi Boinon¹, Elise Douillard^{1

2}, Magali Devic^{1

2}, Florence Magrangeas^{1

2}, Philippe Moreau^{1

3}, Stéphane Minvielle^{1

2}, Cyrille Touzeau^{1

3}, Eric Letouzé^{4

5}

Affiliations

¹ Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Nantes, France.
² University Hospital Hôtel-Dieu, Nantes, France.
³ Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.
⁴ Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Nantes, France. eric.letouze@inserm.fr.
⁵ University Hospital Hôtel-Dieu, Nantes, France. eric.letouze@inserm.fr.

^# Contributed equally.

Published Erratum

Jennifer Derrien et al. Nat Cancer. 2023 Nov.

. 2023 Nov;4(11):1610.

doi: 10.1038/s43018-023-00646-4.

¹ Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Nantes, France.
² University Hospital Hôtel-Dieu, Nantes, France.
³ Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.
⁴ Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Nantes, France. eric.letouze@inserm.fr.
⁵ University Hospital Hôtel-Dieu, Nantes, France. eric.letouze@inserm.fr.

^# Contributed equally.

No abstract available

Erratum for

Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.
Derrien J, Gastineau S, Frigout A, Giordano N, Cherkaoui M, Gaborit V, Boinon R, Douillard E, Devic M, Magrangeas F, Moreau P, Minvielle S, Touzeau C, Letouzé E. Derrien J, et al. Nat Cancer. 2023 Nov;4(11):1536-1543. doi: 10.1038/s43018-023-00625-9. Epub 2023 Aug 31. Nat Cancer. 2023. PMID: 37653140